PWG
CRL icon

Portside Wealth Group’s Charles River Laboratories CRL Stock Holding History

Portside Wealth Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,104
Closed -$217K – 425
2024
Q3 		$217K Sell
1,104
-155
-12% -$32.2K 0.04% 361
2024
Q2 		$260K Sell
1,259
-31
-2% -$7.02K 0.05% 294
2024
Q1 		$350K Buy
1,290
+45
+4% +$10.7K 0.06% 252
2023
Q4 		$294K Sell
1,245
-11
-0.9% -$2.16K 0.05% 268
2023
Q3 		$250K Sell
1,256
-31
-2% -$6.36K 0.05% 277
2023
Q2 		$271K Buy
+1,287
New +$256K 0.05% 274

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return